Active, Not Recruiting
Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy
NCT05167721
- Conditions
- Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +7 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States